Survival and time interval from surgery to the start of chemotherapy for patients with stage II and III colon cancer

by Denis Ganenko, Audrius Dulskas, Žygimantas Kuliešius, Edita Baltruškevičienė, Vincas Urbonas, Eugenijus Stratilatovas
Published 2019-01-01

Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience

by Edita Baltruškevičienė, Ugnius Mickys, Tadas Žvirblis, Rokas Stulpinas, Teresė Pipirienė Želvienė, Eduardas Aleknavičius
Published 2016-04-01

Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding

by Edita Baltruskeviciene, Diana Schveigert, Vaidotas Stankevicius, Ugnius Mickys, Tadas Zvirblis, Jaroslav Bublevic, Kestutis Suziedelis, Eduardas Aleknavicius
Published 2017-09-01

Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not?

by Narimantas E. Samalavicius, Audrius Dulskas, Edita Baltruskeviciene, Giedre Smailyte, Marija Skuciene, Rasa Mikelenaite, Rasa Venslovaite, Eduardas Aleknavicius, Almantas Samalavicius, Raimundas Lunevicius
Published 2016-12-01